The Acute Effect of Dynamic Taping on Upper Body Posture.

May 22, 2023 updated by: Fuat YÜKSEL, Gazi University

The Acute Effect Of Dynamic Taping Applied To The Neck And Back Region On Upper Body Posture In Asymptomatic Male Individuals

The aim of this study was to evaluate the acute effect of Dynamic tape on cervical and thoracic region posture in asymptomatic male individuals.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Fifty-one asymptomatic individuals between the ages of 18 and 32 years were included in the study. The participants in this study were randomised into two groups, named "Dynamic Taping" (mean age± sd: 23.28±3.41 yrs, n=25) and "Sham Taping" (mean age± sd: 25.15±4.13 yrs, n=26). In the Dynamic taping group, tapes were applied with optimal stretching, while in the Sham taping group, tapes were applied without any stretch. All measurements were done before taping and 30 minutes after taping. Craniovertebral, cranio-horizontal and sagittal shoulder angles were calculated with photographic posture analysis, while thoracic kyphosis was evaluated with a digital inclinometer (JTech IQ Pro™, ABD).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
51

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Ankara, Turkey
        • Gazi University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • between the ages of 18-40 years,
  • male gender,
  • not having any injuries to the neck and back region in the last 3 months

Exclusion Criteria:

  • Individuals who were allergic to taping,
  • had neurological or rheumatological disorders
  • felt discomfort after starting the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Dynamic tape on experimental group
As a result of randomization, dynamic tape was applied to 25 people with a special technique.
Other: Dynamic tape on experimental group
The dynamic taping application was carried out in 2 stages. Three "I"-shaped tapes were cut. In the first stage, the person was asked to perform scapular retraction, and in this position, the tape was placed by applying medium tension to the anterior part of the other deltoid muscle, passing from the anterior part of the deltoid muscle to the upper thoracic region. In the second stage, the participant was asked to do scapular retraction and depression, and while maintaining this position, medium tension was applied to the lower thoracic vertebra starting from the anterior part of the deltoid muscle and the acromion and tape was applied. Afterward, this process was applied on the other side
Placebo Comparator: Sham tape on placebo group
As a result of randomization, dynamic tape was applied to 26people with a sham technique.
Other: Sham tape on placebo group
Sham taping was performed in 2 stages. Three "I"-shaped tapes were cut. Participants were asked to stand in the comfortable position they used during the day. The first tape was adhered from the starting point of the spine of the scapula with the acromion to the junction of the spine of the scapula and the acromion on the other side without any tension. The other two tapes, starting from the beginning and ending points of the first tape, were adhered to the lower thoracic region without any tension

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Photographic Posture Assessment
Time Frame: 5 minutes before tape
To take pictures of the participants, the camera (Logitech, Switzerland) was placed on a tripod with a height of 115 cm and at a distance of 1.5 m (33). In order to maintain the same distance between the camera and the participants, a spot on the ground was marked for the subjects to stand, and the tripod was fixed to the ground. The photos were taken of the left side of the subjects in standing position. Before photographing, reflective markers were placed on the lateral canthus, tragus, 7th cervical vertebra, and acromion. During the photography, the subjects were asked to stand in a comfortable position as in daily life.
5 minutes before tape
Photographic Posture Assessment
Time Frame: 15 minutes after tape
o take pictures of the participants, the camera (Logitech, Switzerland) was placed on a tripod with a height of 115 cm and at a distance of 1.5 m (33). In order to maintain the same distance between the camera and the participants, a spot on the ground was marked for the subjects to stand, and the tripod was fixed to the ground. The photos were taken of the left side of the subjects in standing position. Before photographing, reflective markers were placed on the lateral canthus, tragus, 7th cervical vertebra, and acromion. During the photography, the subjects were asked to stand in a comfortable position as in daily life.
15 minutes after tape
Cranio-horizontal angle (Before)
Time Frame: 5 minutes before tape
Photographs were analysed using the "ImageJ" program and CH angle were calculated and data were recorded. This procedure was performed by a researcher blinded to the study. This is the angle between the horizontal line drawn from the tragus and the line drawn from the tragus to the lateral canthus of the eye. It provides information about the position of the head above the neck and the location of the upper cervical spine.
5 minutes before tape
Cranio-horizontal angle (after)
Time Frame: 15 minutes after tape
Photographs were analysed using the "ImageJ" program and CH angle were calculated and data were recorded. This procedure was performed by a researcher blinded to the study. This is the angle between the horizontal line drawn from the tragus and the line drawn from the tragus to the lateral canthus of the eye. It provides information about the position of the head above the neck and the location of the upper cervical spine.
15 minutes after tape
Craniovertebral angle (before)
Time Frame: 5 minutes before tape
Photographs were analysed using the "ImageJ" program and CV angle were calculated and data were recorded. This procedure was performed by a researcher blinded to the study.This is the angle between the horizontal line drawn from the 7th cervical vertebra and the line drawn from the 7th cervical vertebra to the tragus . The CV angle provides information about the position of the lower cervical region and is used in the objective evaluation of FHP.
5 minutes before tape
Craniovertebral angle (after)
Time Frame: 15 minutes after tape
Photographs were analysed using the "ImageJ" program and CV angle were calculated and data were recorded. This procedure was performed by a researcher blinded to the study.This is the angle between the horizontal line drawn from the 7th cervical vertebra and the line drawn from the 7th cervical vertebra to the tragus . The CV angle provides information about the position of the lower cervical region and is used in the objective evaluation of FHP.
15 minutes after tape
Sagittal shoulder posture angle ( Before)
Time Frame: 5 minutes before tape
Photographs were analysed using the "ImageJ" program and SSP angle were calculated and data were recorded. This procedure was performed by a researcher blinded to the study.This is the angle between the horizontal line drawn from the acromion and the line connecting the acromion to the 7th cervical vertebra. This assessment provides information about the position of the shoulder
5 minutes before tape
Sagittal shoulder posture angle (after)
Time Frame: 15 minutes after tape
Photographs were analysed using the "ImageJ" program and SSP angle were calculated and data were recorded. This procedure was performed by a researcher blinded to the study.This is the angle between the horizontal line drawn from the acromion and the line connecting the acromion to the 7th cervical vertebra. This assessment provides information about the position of the shoulder
15 minutes after tape

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Thoracic kyphosis angle (Before)
Time Frame: 5 minutes before tape
TK angle was measured with a dual digital inclinometer (JTech IQ Pro™, USA). Participants were asked to stand in a relaxed position. The dual inclinometer device was placed over the spinous processes of the 1st thoracic vertebra and the 12th thoracic vertebra. The measured angle was recorded as the TK angle.
5 minutes before tape
Thoracic kyphosis angle (after)
Time Frame: 15 minutes after tape
TK angle was measured with a dual digital inclinometer (JTech IQ Pro™, USA). Participants were asked to stand in a relaxed position. The dual inclinometer device was placed over the spinous processes of the 1st thoracic vertebra and the 12th thoracic vertebra. The measured angle was recorded as the TK angle.
15 minutes after tape

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Gazi University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 1, 2022

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
April 1, 2022

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 1, 2022

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 3, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 22, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 24, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 24, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 22, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Efe1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings